Bortezomib–Melphalan–Prednisone (VMP) in Newly Diagnosed Multiple Myeloma Patients with Impaired Renal Function: Cohort Analysis of the Phase III VISTA Study.
暂无分享，去创建一个
M. Dimopoulos | J. Miguel | P. Richardson | E. Kastritis | R. Schots | M. Delforge | T. Masszi | O. Shpilberg | M. Petrucci | M. Mateos | R. Schlag | M. Kropff | A. Cakana | W. Deraedt | H. Velde | K. Liu | Julia Alexeeva | Nuriet K. Khuageva